Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Original languageEnglish (US)
Pages (from-to)126-131
Number of pages6
JournalMethodist DeBakey cardiovascular journal
Issue number3
StatePublished - Jul 1 2017


  • SAVR
  • TAVR
  • expandable valve
  • surgical aortic valve replacement
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes'. Together they form a unique fingerprint.

Cite this